ARTICLE | Company News
Otsuka Pharmaceutical, Takeda sales and marketing update
March 16, 2015 7:00 AM UTC
Takeda and Otsuka launched Takecab vonoprazan fumarate in Japan to treat acid-related diseases. The National Health Insurance (NHI) reimbursement price for a 10 mg tablet is Y160.1 ($1.33) and Y240.2...